HP184 in Chronic Spinal Cord Injury Subjects

Status:
Completed

Trial end date:
2005-12-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether HP184 is effective in the treatment of chronic spinal cord injury (CSCI).

Phase 2

Sanofi